The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
104357297 10435729 7 F 20140703 20160629 20140908 20160706 EXP JP-ASTELLAS-2014JP016111 ASTELLAS 77.13 YR M Y 58.00000 KG 20160706 CN JP JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
104357297 10435729 1 PS XTANDI ENZALUTAMIDE 1 Oral 2560 MG Y N 203415 160 MG CAPSULE QD
104357297 10435729 2 SS XTANDI ENZALUTAMIDE 1 Oral 2560 MG N 203415 80 MG CAPSULE QD
104357297 10435729 3 SS ZOMETA ZOLEDRONIC ACID 1 Unknown 162 MG Y 0 3 MG INJECTION
104357297 10435729 4 SS RANMARK DENOSUMAB 1 Subcutaneous 0 120 MG INJECTION
104357297 10435729 5 C HARNAL TAMSULOSIN HYDROCHLORIDE 1 Oral 0.2 MG, ONCE DAILY U 0 .2 MG ORODISPERSIBLE TABLET QD
104357297 10435729 6 C NEXIUM ESOMEPRAZOLE MAGNESIUM 1 Oral U 0 20 MG CAPSULE QD
104357297 10435729 7 C DECADRON DEXAMETHASONE 1 Oral U 0 1 MG TABLET QD
104357297 10435729 8 C DECADRON DEXAMETHASONE 1 U 0 TABLET
104357297 10435729 9 C ZYLORIC ALLOPURINOL 1 Oral U 0 100 MG TABLET QD
104357297 10435729 10 C MEDICON /00048102/ DEXTROMETHORPHAN HYDROBROMIDE 1 Oral 9000 MG U 0 30 MG TABLET TID
104357297 10435729 11 C MICOMBI COMBINATION HYDROCHLOROTHIAZIDETELMISARTAN 1 Oral UNK, ONCE DAILY U 0 TABLET QD
104357297 10435729 12 C ADALAT CC NIFEDIPINE 1 Oral U 0 20 MG MODIFIED-RELEASE TABLET BID
104357297 10435729 13 C ZOLADEX GOSERELIN ACETATE 1 Subcutaneous 10.8 MG, EVERY 12 WEEKS U 0 10.8 MG INJECTION
104357297 10435729 14 C CALCIUM COMPOUNDS 2 Oral UNK UNK, UNKNOWN FREQ. U 0 PER ORAL NOS

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
104357297 10435729 1 Hormone-refractory prostate cancer
104357297 10435729 3 Metastases to bone
104357297 10435729 4 Metastases to bone
104357297 10435729 5 Dysuria
104357297 10435729 6 Hyperchlorhydria
104357297 10435729 7 Hormone-refractory prostate cancer
104357297 10435729 8 Metastases to bone
104357297 10435729 9 Hyperuricaemia
104357297 10435729 10 Interstitial lung disease
104357297 10435729 11 Hypertension
104357297 10435729 12 Hypertension
104357297 10435729 13 Product used for unknown indication
104357297 10435729 14 Prophylaxis

Outcome of event

Event ID CASEID OUTC COD
104357297 10435729 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
104357297 10435729 Hypocalcaemia
104357297 10435729 Malaise
104357297 10435729 Renal impairment

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
104357297 10435729 1 20140618 20140709 0
104357297 10435729 2 20140828 0
104357297 10435729 3 20100513 20140618 0
104357297 10435729 4 20140730 0
104357297 10435729 5 20140512 0
104357297 10435729 6 20130207 0
104357297 10435729 7 20130306 0
104357297 10435729 9 20130321 0
104357297 10435729 10 20140326 20140709 0
104357297 10435729 13 20100110 0
104357297 10435729 14 20140730 0